科技报告详细信息
| Pharmaceutical Patent Litigation Settlements: Implications for Competition and Innovation | |
| Thomas, John R. | |
| Library of Congress. Congressional Research Service. | |
| 关键词: Drug industry; Drugs; Intellectual property; Patent infringement; Patent law and legislation; | |
| RP-ID : RL33717 RP-ID : RL33717_2011Jan20 |
|
| 美国|英语 | |
| 来源: UNT Digital Library | |
PDF
|
|
【 摘 要 】
This report introduces and analyzes innovation policy issues concerning pharmaceutical patent litigation settlements, including pharmaceutical patent litigation procedures under the Hatch-Waxman Act, the concept of reverse payment settlements, the status of reverse payment settlements under the antitrust laws, and congressional issues and alternatives.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RL33717_2011Jan20.pdf | 1011KB |
PDF